Chairman and CEO, 10% Owner of LeMaitre Vascular Inc. (LMAT, Financial) George W Lemaitre buys 1,000 shares of LMAT on 05/18/2009 at an average price of $2.9 a share.
LEMAITRE VASCULAR INC. is a leading global provider of innovative devices for the treatment of peripheral vascular disease. LeMaitre develops manufactures and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. LeMaitre Vascular Inc. has a market cap of $42.36 million; its shares were traded at around $2.71 with and P/S ratio of 0.87.
Recent Trades of LeMaitre Vascular Inc. by CEO:
LEMAITRE VASCULAR INC. is a leading global provider of innovative devices for the treatment of peripheral vascular disease. LeMaitre develops manufactures and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. LeMaitre Vascular Inc. has a market cap of $42.36 million; its shares were traded at around $2.71 with and P/S ratio of 0.87.
Recent Trades of LeMaitre Vascular Inc. by CEO:
- Buy: Chairman and CEO, 10% Owner George W Lemaitre bought 1,000 shares of LMAT stock on 05/18/2009 at the average price of $2.9; the price of the stock has decreased by 6.55% since.
